Clinical Trials · NCT01943617
Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Beijing Friendship Hospital
- Enrollment
- 606
- Start date
- Jun 2013
- Locations
- 21 sites, China
- Primary endpoint
- Decompensated rate of Liver Cirrhosis after 2 years treatment